These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35700009)

  • 1. Ecologic Analysis of Correlates of Cervical Cancer Morbidity and Mortality in Sub-Saharan Africa.
    Gapare CR; El-Zein M; Patel H; Tope P; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1804-1811. PubMed ID: 35700009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
    BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
    Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
    Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
    Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
    Ba DM; Ssentongo P; Musa J; Agbese E; Diakite B; Traore CB; Wang S; Maiga M
    Cancer Epidemiol; 2021 Jun; 72():101930. PubMed ID: 33756434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
    Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
    Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
    Stewart TS; Moodley J; Walter FM
    Cancer Epidemiol; 2018 Apr; 53():81-92. PubMed ID: 29414636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer: the sub-Saharan African perspective.
    Anorlu RI
    Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
    Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
    PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.
    Perlman S; Wamai RG; Bain PA; Welty T; Welty E; Ogembo JG
    PLoS One; 2014; 9(3):e90912. PubMed ID: 24618636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    de Martel C; Plummer M; Vignat J; Franceschi S
    Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
    Bray F; Parkin DM;
    Lancet Oncol; 2022 Jun; 23(6):719-728. PubMed ID: 35550275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination.
    Ngcobo N; Jaca A; Iwu-Jaja CJ; Mavundza E
    Curr Opin Immunol; 2021 Aug; 71():21-26. PubMed ID: 33857884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis.
    Seyoum A; Assefa N; Gure T; Seyoum B; Mulu A; Mihret A
    Front Public Health; 2022; 10():890880. PubMed ID: 35875040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS; de Sanjose S; Mayaud P
    Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.